Skip to main content
. 2021 Oct 12;2021(10):CD011589. doi: 10.1002/14651858.CD011589.pub2

Mamguem Kanga 2020.

Study name  
Methods Randomised trial, France. 
Participants Women with non‐metastatic hormone receptor‐positive breast cancer. 
Interventions Health‐related quality of life assessment with delivery of scores to clinicians vs usual care. 
Outcomes Primary outcome: compliance with endocrine therapy at 12 months. 
Starting date  
Contact information  
Notes The study was funded by the Georges François LeClerc Center, Burgundy, France.